Docetaxel trials for Non-small Cell Lung Cancer (NSCLC)

All Docetaxel trials · All Non-small Cell Lung Cancer (NSCLC) trials

Phase breakdown

Recruiting trials studying Docetaxel for Non-small Cell Lung Cancer (NSCLC)

• A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
  NCT07566052 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
  NCT07291037 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 205 locations
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
  NCT05176483 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 244 locations

Common questions

How many trials study Docetaxel for Non-small Cell Lung Cancer (NSCLC)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.